Navigation Links
WHO’s asking :Is There Light At The End Of The Tunnel In Tajikistan

The helm of affairs at the World Health Organization's (WHO) mission in Tajikistan, Santino Severoni, has an unenviable agenda in front of him. Tajikistan is reeling under a malnourished public health system, // bruised after the five –year civil war, and has left a trail of devastation that is calling for urgent remedy.

Severoni, 42, a key contributor as a surgeon in Somalia, Sudan, Kenya, Burundi and Tanzania, and has been a witness to all the four civil wars that have ravaged these countries.

Tajikistan’s health care facilities need a major revamp especially in areas like obstetric services, issues of infectious diseases, tuberculosis, malaria, HIV/AIDS and others. There have been extreme difficulties in access to quality healthcare in remote areas, and a dearth of necessary special equipment at health facilities. Infant and maternal mortality rates have always been high in Tajikistan, with nearly 70 percent of women not enabled with pre-natal care.

In the words of, Santino Severoni , “Therefore, it has been decided to increase WHO's support to Tajikistan and to boost the staff of WHO's mission in the country. WHO intends to provide quality resources to support the country's public health system. Usually WHO does not work in the system of infrastructure, but provides technical assistance via the health ministry”

'"/>




Page: 1

Related medicine news :

1. Brazil & Kenya Seek Support For A New Resolution At WHO’s Annual Mee
2. Therapeutic Genes Transferred By Viral Vector Through T Cell Masking
3. Masking A Flu? – Wearing Masks, Only Way to Contain It’s Spred
4. Unmasking Nutritions Role in Genes and Birth Defects
5. Scientists Develop a Harmless Multi-Tasking Reovirus
6. Could There Be A Link Between Famine and Breast Cancer ?
7. Can There Be A Diabetes Type III?
8. Diabetic Amputation May Reduce If Free Screenings Are There
9. Hospital Says There Is Time but Baby Decides Otherwise
10. There is light at the end of the blind tunnel: prosthetic retinal cells offer hope!
11. Is There A Strong Link Between Fluoride In Tap Water And Bone Cancer?
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2017)... ... , ... IndustryArchive.Org . is announcing a new way for B2B Sellers ... only pay for B.A.N.T. quality sales leads based on the Sellers decision to purchase ... reality that B2B buyers are controlling the sales process via the Internet and that ...
(Date:2/26/2017)... ... , ... ODH, Inc.™ announced today it will exhibit and speak at ... Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present ... population health management. , ODH will also have an exhibit booth where attendees may ...
(Date:2/26/2017)... ... February 26, 2017 , ... Occupational pesticide exposure ... a specific LRRK2 mutation, according to a study released today at the 1st ... of a link between pesticides and incidence of sporadic PD through occupational exposure. ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... its newly designed TaskMate Go. Core benefits and advantages built into the home ... a stylish, functional look and feel. Ability to gain the benefits embedded in ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the ... Market (ILTM) show in Cannes (France), XO Private has initiated a second print-run of ... book measures almost a metre across when open, weighs in at more than six ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une société de ... excellents résultats semestriels clos le 31 décembre 2016 par ... « Résultats et mise à jour sur la croissance biomédicale ... Faits marquants Bénéfice ... hausse de 104 %) Bénéfice par action ...
(Date:2/24/2017)... 2017 Non-alcoholic steatohepataitis (NASH) Pipeline ... drugs being developed for the treatment of ... that are in various phases of development ... on novel pharmacologic drugs & regenerative medicines ... recombinant proteins and RNA-based therapeutics, but excludes ...
(Date:2/24/2017)... Wyoming , Feb. 24, 2017  Xynomic Pharmaceuticals, ... today announced that it has acquired exclusive worldwide ... potentially best-in-class innovative HDAC inhibitor targeting hematological and ... of 14 Phase 1 and 2 clinical trials ... Asia have already been completed, demonstrating ...
Breaking Medicine Technology: